188 related articles for article (PubMed ID: 32328480)
1. Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics.
Mao Y; Liu X
Front Chem; 2020; 8():257. PubMed ID: 32328480
[TBL] [Abstract][Full Text] [Related]
2. Radionanomedicine: Advanced Strategy for Precision Theranostics of Breast Cancer.
Guo Y; Liu X
J Biomed Nanotechnol; 2022 Jan; 18(1):50-60. PubMed ID: 35180899
[TBL] [Abstract][Full Text] [Related]
3. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
[TBL] [Abstract][Full Text] [Related]
4. "Stepwise Extraction" strategy-based injectable bioresponsive composite implant for cancer theranostics.
Yang B; Lin H; Dai C; Chen Y; Shi J
Biomaterials; 2018 Jun; 166():38-51. PubMed ID: 29533789
[TBL] [Abstract][Full Text] [Related]
5. Synergistic nanomedicine by combined gene and photothermal therapy.
Kim J; Kim J; Jeong C; Kim WJ
Adv Drug Deliv Rev; 2016 Mar; 98():99-112. PubMed ID: 26748259
[TBL] [Abstract][Full Text] [Related]
6. Bioresponsive Nanomaterials: Recent Advances in Cancer Multimodal Imaging and Imaging-Guided Therapy.
Zeng Z; Gao H; Chen C; Xiao L; Zhang K
Front Chem; 2022; 10():881812. PubMed ID: 35372260
[TBL] [Abstract][Full Text] [Related]
7. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
Wang Y; Cai R; Chen C
Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared light-responsive nanomaterials for cancer theranostics.
Kim H; Chung K; Lee S; Kim DH; Lee H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
[TBL] [Abstract][Full Text] [Related]
9. Reactive Oxygen Species (ROS)-Responsive Nanomedicine for Solving Ischemia-Reperfusion Injury.
Chen W; Li D
Front Chem; 2020; 8():732. PubMed ID: 32974285
[TBL] [Abstract][Full Text] [Related]
10. Functional nanomaterials for near-infrared-triggered cancer therapy.
Liu B; Li C; Cheng Z; Hou Z; Huang S; Lin J
Biomater Sci; 2016 Jun; 4(6):890-909. PubMed ID: 26971704
[TBL] [Abstract][Full Text] [Related]
11. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
12. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms.
Wang C; Dai C; Hu Z; Li H; Yu L; Lin H; Bai J; Chen Y
Nanoscale Horiz; 2019 Mar; 4(2):415-425. PubMed ID: 32254094
[TBL] [Abstract][Full Text] [Related]
13. Recent advances of bioresponsive polymeric nanomedicine for cancer therapy.
Hong T; Shen X; Syeda MZ; Zhang Y; Sheng H; Zhou Y; Xu J; Zhu C; Li H; Gu Z; Tang L
Nano Res; 2023; 16(2):2660-2671. PubMed ID: 36405982
[TBL] [Abstract][Full Text] [Related]
14. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
Sun SK; Wang HF; Yan XP
Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
Zhou LQ; Li P; Cui XW; Dietrich CF
Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Managing Atherosclerosis via Nanomedicine.
Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
Small; 2018 Jan; 14(4):. PubMed ID: 29239134
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review.
Karthic A; Roy A; Lakkakula J; Alghamdi S; Shakoori A; Babalghith AO; Emran TB; Sharma R; Lima CMG; Kim B; Park MN; Safi SZ; de Almeida RS; Coutinho HDM
Front Cell Dev Biol; 2022; 10():984311. PubMed ID: 36158215
[TBL] [Abstract][Full Text] [Related]
18. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
19. Bioresponsive Polymers for Nanomedicine-Expectations and Reality!
Quader S; Van Guyse JFR
Polymers (Basel); 2022 Sep; 14(17):. PubMed ID: 36080733
[TBL] [Abstract][Full Text] [Related]
20. From Dyestuff Chemistry to Cancer Theranostics: The Rise of Rylenecarboximides.
Ji C; Cheng W; Yuan Q; Müllen K; Yin M
Acc Chem Res; 2019 Aug; 52(8):2266-2277. PubMed ID: 31373482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
